ME
McIlrath & Eck’s Sanofi SNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-966
| Closed | -$46.9K | – | 990 |
|
|
2024
Q1 | $46.9K | Buy |
966
+353
| +58% | +$17.2K | 0.01% | 284 |
|
|
2023
Q4 | $30.5K | Buy |
613
+361
| +143% | +$18K | 0.01% | 334 |
|
|
2023
Q3 | $13.5K | Hold |
252
| – | – | ﹤0.01% | 478 |
|
|
2023
Q2 | $13.6K | Hold |
252
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $13.7K | Buy |
+252
| New | +$13.7K | ﹤0.01% | 488 |
|
|
2022
Q2 | – | Sell |
-270
| Closed | -$14K | – | 872 |
|
|
2022
Q1 | $14K | Hold |
270
| – | – | ﹤0.01% | 473 |
|
|
2021
Q4 | $14K | Hold |
270
| – | – | ﹤0.01% | 485 |
|
|
2021
Q3 | $13K | Hold |
270
| – | – | ﹤0.01% | 485 |
|
|
2021
Q2 | $14K | Hold |
270
| – | – | ﹤0.01% | 468 |
|
|
2021
Q1 | $13K | Hold |
270
| – | – | ﹤0.01% | 438 |
|
|
2020
Q4 | $13K | Hold |
270
| – | – | ﹤0.01% | 373 |
|
|
2020
Q3 | $14K | Hold |
270
| – | – | 0.01% | 324 |
|
|
2020
Q2 | $14K | Sell |
270
-70
| -21% | -$3.63K | 0.01% | 301 |
|
|
2020
Q1 | $15K | Buy |
340
+70
| +26% | +$3.09K | 0.01% | 246 |
|
|
2019
Q4 | $14K | Hold |
270
| – | – | 0.01% | 308 |
|
|
2019
Q3 | $13K | Hold |
270
| – | – | 0.01% | 298 |
|
|
2019
Q2 | $12K | Hold |
270
| – | – | 0.01% | 296 |
|
|
2019
Q1 | $12K | Sell |
270
-353
| -57% | -$15.7K | 0.01% | 296 |
|
|
2018
Q4 | $27K | Hold |
623
| – | – | 0.02% | 160 |
|
|
2018
Q3 | $28K | Hold |
623
| – | – | 0.02% | 172 |
|
|
2018
Q2 | $25K | Buy |
+623
| New | +$25K | 0.02% | 171 |
|